ClinicalThought

Share

Program Content

Activities

  • R/R ALL
    How I Use Blinatumomab and Inotuzumab Ozogamicin in Patients With Relapsed/Refractory ALL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 30, 2020

    Expires: September 29, 2021

Faculty

cover img faculity

David Marks, MD, PhD

Professor of Haematology and Stem Cell Transplanation
Department of Haematology and BMT
University of Bristol
University Hospitals Bristol NHS
Bristol, United Kingdom

Provided by

ProCE Banner

Supporters

Pfizer, Inc.